Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.62 USD | +3.22% | +5.48% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 214M |
---|---|---|---|---|---|
Net income 2024 * | -70M | Net income 2025 * | -98M | EV / Sales 2024 * | - |
Net cash position 2024 * | 30.75M | Net cash position 2025 * | 36.28M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-2.19
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.54% |
1 day | +3.22% | ||
1 week | +5.48% | ||
Current month | +5.48% | ||
1 month | +5.71% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 9.62 | +3.22% | 41,911 |
24-06-06 | 9.32 | +4.02% | 25,436 |
24-06-05 | 8.96 | -2.50% | 44,564 |
24-06-04 | 9.19 | +1.21% | 38,533 |
24-06-03 | 9.08 | -0.44% | 39,182 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 214M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.16% | 22.78B | |
-10.97% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- BOLD Stock